AstraZeneca aims to widen the pool of bladder ... In the company’s POTOMAC phase 3 study, patients with high-risk NMIBC who were treated with Imfinzi for one year—along with standard-of ...

New Delhi: UK pharma major AstraZeneca in partnership with health ... including lung nodules at high risk for cancer in nearly 50,000 people who were later referred for further testing and ...

AstraZeneca Plc’s experimental cholesterol ... according to data presented at the American College of Cardiology in Chicago. High levels of this form of cholesterol are a key risk factor in ...

AstraZeneca Plc’s experimental cholesterol ... according to data presented at the American College of Cardiology in Chicago. High levels of this cholesterol are a key risk factor in strokes ...

We recently compiled a list of 10 High Growth NASDAQ Stocks That Are Profitable in 2024. In this article, we will look at where AstraZeneca PLC (NASDAQ:AZN) ranks among the high-growth NASDAQ ...

Commentary: Apple Intelligence was supposed to be the headline feature on Apple's new phones, but a new slow-mo video setting steals the show. Patrick Holland has been a phone reviewer for CNET ...

We recently compiled a list of the 14 Best 52-Week High Stocks to Buy According to Short Sellers. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against the ...

AstraZeneca ADRs rose to a record high Tuesday following the announcement. AstraZeneca's (AZN) American depositary receipts (ADRs) rose over 2% to a record high Tuesday after the Anglo-Swedish ...

London's FTSE on Wednesday 100 stock index soared to unprecedented levels, buoyed by AstraZeneca's strong performance. The pharmaceutical company's global decision to halt its COVID-19 vaccine ...

Cambridge-based AstraZeneca, which is contesting the legal battle, acknowledged in a legal document submitted to the High Court in February that its vaccine 'can, in very rare cases, cause TTS'.

Cambridge-based AstraZeneca, which is contesting the claims, acknowledged in a legal document submitted to the High Court in February that its vaccine 'can, in very rare cases, cause TTS'.

AstraZeneca and Daiichi Sankyo's Enhertu showed positive high-level results of improvement in PFS compared to standard-of-care chemotherapy in the primary trial population of patients. Enhertu is ...